Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Salerno

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Epidemiologia E Prevenzione|December 16, 2024
[Newborn hearing and eye screenings: recommendations]Domenica Taruscio, Paolo Salerno
Annali Dell'Istituto Superiore Di Sanita|September 26, 2019
Primary prevention as an essential factor ensuring sustainability of health systems: the example of congenital anomaliesDomenica Taruscio, Eva Bermejo-Sánchez, Paolo Salerno, et al.
Cancer Research|February 19, 2009
Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinomaTito Claudio Nappi, Paolo Salerno, Horst Zitzelsberger, et al.
Experimental and Molecular Pathology|May 21, 2013
Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinomaJena Hudson, Eric Duncavage, Anna Tamburrino, et al.
The Journal of Clinical Endocrinology and Metabolism|May 23, 2014
Identification of targets of Twist1 transcription factor in thyroid cancer cellsGennaro Di Maro, Francesca Maria Orlandella, Tammaro Claudio Bencivenga, et al.
Epigenetics & Chromatin|April 17, 2026
Loss of maternal PADI6 disrupts DNA methylation and genomic imprinting maintenance in late preimplantation mouse embryosCarlo Giaccari, Francesco Cecere, Angela Pagano, et al.
The Journal of Clinical Endocrinology and Metabolism|November 3, 2009
Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cellsPaolo Salerno, Valentina De Falco, Anna Tamburrino, et al.
Endocrine Reviews|February 16, 2017
Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma CellsPaolo Salerno, Valentina De Falco, Anna Tamburrino, et al.
Cancer Research|December 20, 2007
Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancerValentina De Falco, Valentina Guarino, Elvira Avilla, et al.
Endocrine-Related Cancer|February 13, 2019
Association between DNA methylation profile and malignancy in follicular-patterned thyroid neoplasmsOrnella Affinito, Paolo Salerno, Alfonso D'Alessio, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Epidemiologia E Prevenzione|December 16, 2024
[Newborn hearing and eye screenings: recommendations]Domenica Taruscio, Paolo Salerno
Annali Dell'Istituto Superiore Di Sanita|September 26, 2019
Primary prevention as an essential factor ensuring sustainability of health systems: the example of congenital anomaliesDomenica Taruscio, Eva Bermejo-Sánchez, Paolo Salerno, et al.
Cancer Research|February 19, 2009
Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinomaTito Claudio Nappi, Paolo Salerno, Horst Zitzelsberger, et al.
Experimental and Molecular Pathology|May 21, 2013
Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinomaJena Hudson, Eric Duncavage, Anna Tamburrino, et al.
The Journal of Clinical Endocrinology and Metabolism|May 23, 2014
Identification of targets of Twist1 transcription factor in thyroid cancer cellsGennaro Di Maro, Francesca Maria Orlandella, Tammaro Claudio Bencivenga, et al.
Epigenetics & Chromatin|April 17, 2026
Loss of maternal PADI6 disrupts DNA methylation and genomic imprinting maintenance in late preimplantation mouse embryosCarlo Giaccari, Francesco Cecere, Angela Pagano, et al.
The Journal of Clinical Endocrinology and Metabolism|November 3, 2009
Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cellsPaolo Salerno, Valentina De Falco, Anna Tamburrino, et al.
Endocrine Reviews|February 16, 2017
Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma CellsPaolo Salerno, Valentina De Falco, Anna Tamburrino, et al.
Cancer Research|December 20, 2007
Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancerValentina De Falco, Valentina Guarino, Elvira Avilla, et al.
Endocrine-Related Cancer|February 13, 2019
Association between DNA methylation profile and malignancy in follicular-patterned thyroid neoplasmsOrnella Affinito, Paolo Salerno, Alfonso D'Alessio, et al.
Pageof 3